Stock A099190 I-SENS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials i-SENS, Inc.

Equities

A099190

KR7099190001

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 15/05/2024 BST 		5-day change 1st Jan Change
19,880 KRW -0.60% Intraday chart for i-SENS, Inc. +0.61% -30.49%
04-30 I-SENS, Inc. announced that it has received KRW 50 billion in funding from NH Investment & Securities Co., Ltd., Atinum Investment Co., Ltd CI
04-26 I-SENS, Inc. announced that it expects to receive KRW 50 billion in funding from NH Investment & Securities Co., Ltd., Atinum Investment Co., Ltd CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 349,393 407,852 411,251 451,768 786,743 549,235 - -
Enterprise Value (EV) 2 345.5 407.9 411.3 451.8 786.7 663.8 692.3 701.6
P/E ratio 14.6 x 15.2 x 16.4 x 27.7 x 213 x 18.4 x 12.5 x -
Yield 0.78% 0.83% 0.99% 1.06% - 0.5% 0.75% 0.5%
Capitalization / Revenue 1.84 x 2 x 1.77 x 1.7 x 2.97 x 1.82 x 1.45 x 1.34 x
EV / Revenue 1.82 x 2 x 1.77 x 1.7 x 2.97 x 2.2 x 1.82 x 1.71 x
EV / EBITDA 8.6 x 10.3 x 8.99 x 14.2 x 32.1 x 25.4 x 12.6 x 18.5 x
EV / FCF 11.1 x 15.1 x - -29.5 x - 51.1 x 19.2 x -
FCF Yield 8.98% 6.61% - -3.39% - 1.96% 5.2% -
Price to Book 1.76 x 1.86 x 1.53 x 0.79 x - 2.2 x 1.7 x 2.12 x
Nbr of stocks (in thousands) 27,190 27,190 27,190 27,463 27,508 27,627 - -
Reference price 3 12,850 15,000 15,125 16,450 28,600 19,880 19,880 19,880
Announcement Date 04/02/20 03/02/21 27/01/22 01/02/23 13/02/24 - - -
1KRW in Million2KRW in Billions3KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 189.8 203.7 233 265.3 265.1 302 379.8 411.3
EBITDA 1 40.19 39.67 45.72 31.86 24.49 26.1 54.83 38
EBIT 1 31.86 30.34 35.34 20.11 11.29 10.9 39.93 15.9
Operating Margin 16.78% 14.89% 15.17% 7.58% 4.26% 3.61% 10.51% 3.87%
Earnings before Tax (EBT) 1 35.58 34.84 31.36 19.74 7.125 36.3 53 -
Net income 1 29.5 26.58 24.59 14.41 4.79 29.7 44 -
Net margin 15.54% 13.05% 10.55% 5.43% 1.81% 9.83% 11.58% -
EPS 2 877.5 986.5 919.5 593.0 134.0 1,081 1,591 -
Free Cash Flow 3 31,025 26,976 - -15,333 - 13,000 36,000 -
FCF margin 16,344.07% 13,243.86% - -5,778.28% - 4,304.64% 9,477.84% -
FCF Conversion (EBITDA) 77,198.2% 68,005.4% - - - 49,808.43% 65,653.5% -
FCF Conversion (Net income) 105,187.74% 101,505.66% - - - 43,771.04% 81,818.18% -
Dividend per Share 2 100.0 125.0 150.0 175.0 - 100.0 150.0 100.0
Announcement Date 04/02/20 03/02/21 27/01/22 01/02/23 13/02/24 - - -
1KRW in Billions2KRW3KRW in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 59.01 63.03 68.82 61.76 68.51 66.25 62.49 67.04 74.94 68.4 72.2 76.6 84.6
EBITDA - - - - - - - - - - - - -
EBIT 1 9.461 6.764 9.811 7.342 3.469 -0.837 3.838 -0.449 3.037 0.8097 2.5 4 3.6
Operating Margin 16.03% 10.73% 14.26% 11.89% 5.06% -1.26% 6.14% -0.67% 4.05% 1.18% 3.46% 5.22% 4.26%
Earnings before Tax (EBT) 9.346 1.343 14.58 5.314 3.911 -3.349 - - - - - - -
Net income 6.984 1.798 13 2.431 2.833 -3.008 - - -2.417 - - - -
Net margin 11.84% 2.85% 18.89% 3.94% 4.13% -4.54% - - -3.23% - - - -
EPS - - - - - - - - - - - - -
Dividend per Share - - - - - - - - - - - - -
Announcement Date 27/10/21 27/01/22 03/05/22 28/07/22 28/10/22 01/02/23 11/08/23 03/11/23 13/02/24 13/05/24 - - -
1KRW in Billions
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - 115 143 152
Net Cash position 1 3.89 - - - - - - -
Leverage (Debt/EBITDA) - - - - - 4.391 x 2.61 x 4.011 x
Free Cash Flow 2 31,025 26,976 - -15,333 - 13,000 36,000 -
ROE (net income / shareholders' equity) 12.4% 12.8% 10.3% 5.23% 1.57% 1.4% 9.33% 1.8%
ROA (Net income/ Total Assets) 9% 9.3% 6.8% 3.67% - 0.8% 6.03% 0.9%
Assets 1 327.8 285.7 361.5 392.4 - 3,712 729.3 -
Book Value Per Share 3 7,303 8,073 9,869 20,814 - 9,050 11,725 9,356
Cash Flow per Share 3 1,395 1,272 632.0 242.0 - 1,713 2,308 -
Capex 1 6.93 7.64 47.6 22 - 22.1 17.1 32
Capex / Sales 3.65% 3.75% 20.44% 8.29% - 7.32% 4.5% 7.78%
Announcement Date 04/02/20 03/02/21 27/01/22 01/02/23 13/02/24 - - -
1KRW in Billions2KRW in Million3KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for i-SENS, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
19,880 KRW
Average target price
34,750 KRW
Spread / Average Target
+74.80%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Medical Equipment

1st Jan change Capi.
I-SENS, INC. Stock i-SENS, Inc.
-30.49% 408M
SHOCKWAVE MEDICAL, INC. Stock Shockwave Medical, Inc.
+73.64% 12.42B
PENUMBRA, INC. Stock Penumbra, Inc.
-19.88% 7.81B
MASIMO CORPORATION Stock Masimo Corporation
+2.90% 6.4B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD. Stock Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
+13.65% 5.45B
APT MEDICAL INC. Stock APT Medical Inc.
+40.00% 5.01B
GETINGE AB Stock Getinge AB
-15.25% 4.84B
ASAHI INTECC CO., LTD. Stock Asahi Intecc Co., Ltd.
-19.71% 4.19B
INARI MEDICAL, INC. Stock Inari Medical, Inc.
-28.70% 2.69B
NOVOCURE LIMITED Stock NovoCure Limited
+48.49% 2.39B
Medical Equipment
  1. Stock Market
  2. Equities
  3. A099190 Stock
  4. Financials i-SENS, Inc.